Foreign body-induced granulation tissue is a source of adult stem cells

Translational Research

Volumn 155, Issue 4, 2010, Pages 191-199

  Patel, Jilpa ^a   Gudehithlu, Krishnamurthy P ^a,b   Dunea, George ^a,b,c   Arruda, Jose A L ^b,c   Singh, Ashok K ^a,b  

^a HEKTOEN INSTITUTE OF MEDICINE   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FOREIGN BODY; GRANULATION TISSUE; HEMATOPOIETIC CELL; MESENCHYME CELL; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 77949440621     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.08.010     Document Type: Article

References (37)

1. Gudehithlu K.P., Ahmed N., Wu H., et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J Lab Clin Med 145 (2005) 194-203
2. Singh A.K., Gudehithlu K.P., Patri S., et al. Impaired integration of endothelial progenitor cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion. Transl Res 149 (2007) 282-291
3. Kreisberg J.I., Hoover R.L., and Karnovsky M.J. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14 (1978) 21-30
4. Singh A.K., Gudehithlu K.P., Pegoraro A.A., et al. Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Lab Invest 84 (2004) 597-606
5. Sam R., Wanna L., Gudehithlu K.P., et al. Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation. Transl Res 148 (2006) 142-148
6. Singh A.K., Patel J., Litbarg N.O., et al. Stromal cells cultured from omentum express pluripotent markers, produce high amounts of VEGF, and engraft to injured sites. Cell Tissue Res 332 (2008) 81-88
7. Litbarg N.O., Gudehithlu K.P., Sethupathi P., Arruda J.A., Dunea G., and Singh A.K. Activated omentum becomes rich in factors that promote healing and tissue regeneration. Cell Tissue Res 328 (2007) 487-497
8. Pesce M., and Schöler H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19 (2001) 271-278
9. Gerrard L., Zhao D., Clark A.J., and Cui W. Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23 (2005) 124-133
10. Hatano S.Y., Tada M., Kimura H., et al. Pluripotential competence of cells associated with Nanog activity. Mech Dev 122 (2005) 67-79
11. Peled A., Petit I., Kollet O., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283 (1999) 845-848
12. Izadpanah R., Joswig T., Tsien F., Dufour J., Kirijan J.C., and Bunnell B.A. Characterization of multipotent mesenchymal stem cells from the bone marrow of rhesus macaques. Stem Cells Dev 14 (2005) 440-451
13. Musina R.A., Bekchanova E.S., and Sukhikh G.T. Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med 139 (2005) 504-509
14. Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
15. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
16. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56 (1999) 794-814
17. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
18. Grove J.E., Bruscia E., and Krause D.S. Plasticity of bone marrow-derived stem cells. Stem Cells 22 (2004) 487-500
19. Tögel F., Isaac J., Hu Z., Weiss K., and Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67 (2005) 1772-1784
20. Kayali A.G., Van Gunst K., Campbell I.L., et al. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163 (2003) 859-869
21. Niku M., Ilmonen L., Pessa-Morikawa T., and Iivanainen A. Limited contribution of circulating cells to the development and maintenance of nonhematopoeitic bovine tissues. Stem Cells 22 (2004) 12-20
22. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13 (2002) 4279-4295
23. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
24. Taylor G., Lehrer M.S., Jensen P.J., Sun T.T., and Lavker R.M. Involvement of follicular stem cells in forming not only the follicles but also the epidermis. Cell 102 (2000) 451-461
25. Oshima H., Rochat A., Kedzia C., Kobayashi K., and Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 104 (2001) 233-245
26. Oliver J.A., Maarouf O., Cheema F.H., Martens T.P., and Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 114 (2004) 795-804
27. Bussolati B., Bruno S., and Grange C. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166 (2005) 545-555
28. Diaz-Flores Jr. L., Gutierrez R., Madrid J.F., Varela H., Valladares F., and Diaz-Flores L. Adult stem cells and repair through granulation tissue. Front Biosci 14 (2009) 1433-1470
29. Díaz-Flores L., Gutiérrez R., Madrid J.F., et al. Pericytes. morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24 (2009) 909-969
30. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
31. Arnhold S., Klein H., Semkova I., Addicks K., and Schraermeyer U. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 45 (2004) 4251-4255
32. Curzer H. The ethics of embryonic stem cell research. J Med Philos 29 (2004) 533-562
33. Chambers I., and Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23 (2004) 7150-7160
34. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., and Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 33 (2005) 1526-1530
35. Hopkins C., Li J., Rae F., and Little M.H. Stem cell options for kidney disease. J Pathol 217 (2009) 265-281
36. Lange C., Tögel F., Ittrich H., et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68 (2005) 1613-1617
37. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73 (2002) 1919-1925